Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing the Usability of the REThink Game and the Efficacy of Its Main Game-based ER Strategies on the Stress Reactivity of Children and Adolescents

NCT05257642 is registered in ClinicalTrials.gov with Babes-Bolyai University as lead sponsor.

NCT NCT05257642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05257642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing the Usability of the REThink Game and the Efficacy of Its Main Game-based ER Strategies on the Stress Reactivity of Children and Adolescents
Lead sponsor
Babes-Bolyai University
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2022
Completion date
November 15, 2022
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emotion regulation